FTXH
First Trust Nasdaq Pharmaceuticals ETF
1W: +1.3%
1M: +5.5%
3M: +12.6%
YTD: +32.2%
1Y: +49.0%
3Y: +81.8%
5Y: +78.9%
Error: Binder Error: Contents of view were altered: types don't match! Expected [VARCHAR, VARCHAR, VARCHAR, DOUBLE, DOUBLE, DOUBLE, BIGINT, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, VARCHAR], but found [VARCHAR, VARCHAR, VARCHAR, DOUBLE, DOUBLE, DOUBLE, BIGINT, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, BIGINT, VARCHAR] instead
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Key Statistics
AUM$1.2B
Holdings50
Top 10 Wt54.8%
Volume24,096
Avg Volume507,720
Beta0.46
Portfolio Fundamentals
P/E47.3
P/B10.5
Div Yield1.41%
ROE22.4%
% Profitable55%
Inception2016-09-22
Sector Allocation
Healthcare
99.9%
Other
0.1%
Top 10 Holdings
| # | Name | Ticker | Weight % | Market Value | Shares |
|---|---|---|---|---|---|
| 1 | AbbVie Inc. | ABBV | 7.68% | $88.6M | 309,254 |
| 2 | Eli Lilly and Company | LLY | 7.62% | $87.9M | 68,552 |
| 3 | Pfizer Inc. | PFE | 7.20% | $83.0M | 2,786,339 |
| 4 | Johnson & Johnson | JNJ | 6.95% | $80.2M | 298,296 |
| 5 | Merck & Co., Inc. | MRK | 6.60% | $76.1M | 536,674 |
| 6 | Biogen Inc. | BIIB | 4.01% | $46.3M | 183,012 |
| 7 | Viatris Inc. | VTRS | 3.90% | $45.0M | 2,401,556 |
| 8 | Gilead Sciences, Inc. | GILD | 3.74% | $43.1M | 270,934 |
| 9 | Amgen Inc. | AMGN | 3.58% | $41.3M | 92,226 |
| 10 | United Therapeutics Corporation | UTHR | 3.54% | $40.8M | 68,966 |